Alanine aminotransferase (ALT) demonstrated a mild downward trend over time, with slightly lower median values after dapagliflozin initiation and at one-year follow-up compared with the pre-treatment period; however, these changes did not reach statistical significance. 3.5.
← all excerpts
Uncoupling Erythropoiesis from Cardiorenal Effects: SGLT2 Inhibition in Non-Diabetic Heart Failure.
1
—
—